Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Fengchun Pharmaceutical is a prominent Chinese pharmaceutical enterprise primarily focused on the modernization and production of Traditional Chinese Medicine (TCM). Established in 1998 and headquartered in Zhongjiang, Sichuan, the company operates as a core subsidiary of the Fengchun Group. Its product portfolio encompasses a wide range of dosage forms, including ointments, tablets, capsules, and granules, with a particular market strength in anorectal and anti-inflammatory treatments. The company maintains large-scale, GMP-certified manufacturing facilities and integrates herbal cultivation with advanced extraction technologies. Sichuan Fengchun Pharmaceutical is recognized for its flagship brand, which serves both domestic and international markets with high-quality herbal-based healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sichuan Fengchun Pharmaceutical.